Plain-English translation of NCT06201403 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how COPD affects the strength and function of your breathing muscles—both the main ones you use to breathe and the helper muscles that kick in when you're struggling. They'll use a device called MyotonPro to gently measure how these muscles feel and perform, then compare results between people with COPD and people without lung disease.
COPD makes breathing harder because the airways narrow and the lungs lose elasticity, but we still don't fully understand how the disease changes the actual muscles involved in breathing. Learning this could help doctors find better ways to help people with COPD stay stronger and breathe easier.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for the study team to use the MyotonPro device on your breathing muscles and other muscles in your body. The device is handheld and painless—it gently touches your skin to measure muscle properties. The visit should take about an hour, and there are no medications to take or invasive procedures involved.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Turkey (Türkiye)
Enrollment target
~66 participants
Started
January 2024
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
ESRA PEHLİVAN
Istanbul Medipol University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.